[Alpha 1 antitrypsin deficiency]
- PMID: 327145
[Alpha 1 antitrypsin deficiency]
Abstract
Alpha-1-antitrypsin (alpha-1-AT) is a potent protease inhibitor. Its deficiency predisposes to serious diseases such as "neonatal hepatitis" and "obstructive pulmonary emphysema". Due to the existence of multiple codominant alleles at one single locus, there are several genetic variants from alpha-1-AT. In homozygous persons the protease inhibitor type (Pi type) MM is prevailing, in heterozygous persons the Pi types MZ and MS. So far one knows at least 24 different alleles. Their phenotypes differ as well in their electrophoretic position as in the protein concentration of the serum. Pi type MM guarantees a normal concentration of alpha-1-AT in the serum, whereas Pi type ZZ causes of serious alpha-1-AT deficiency which bears a particularly high risk of disease.
Similar articles
-
alpha 1-Antitrypsin deficiency.South Med J. 1984 Apr;77(4):479-83. South Med J. 1984. PMID: 6324384 Review.
-
[Liver diseases in children and their relatives with homozygous and heterozygous alpha 1-antitrypsin deficiency].Wien Klin Wochenschr. 1987 Feb 6;99(3):84-91. Wien Klin Wochenschr. 1987. PMID: 3495072 German.
-
Association of alpha 1-antitrypsin deficiency with lung and liver diseases.West J Med. 1987 Jul;147(1):48-53. West J Med. 1987. PMID: 3321708 Free PMC article. Review.
-
Alpha-1-antitrypsin deficiency in New Zealand.N Z Med J. 1975 May 28;81(540):461-7. N Z Med J. 1975. PMID: 1080264
-
Epidemiology of alpha 1-protease inhibitor deficiency.Eur Respir J Suppl. 1990 Mar;9:29s-34s. Eur Respir J Suppl. 1990. PMID: 2340048
Publication types
MeSH terms
LinkOut - more resources
Research Materials
Miscellaneous